Covid treatments: Still struggling for mass uptake ...Middle East

Daily Sun - News
Covid treatments: Still struggling for mass uptake
PARIS: Several treatments are now available to fight Covid-19 but tight timelines, unequal access and weakening effectiveness against new variants have limited their ability to blunt the worst of the pandemic.- Antivirals -Antiviral drugs, which suppress the ability of the virus to multiply in the body’s cells, treat an infection in its early stages, reducing the severity and duration of symptoms.Last week the World Health Organization “strongly recommended” Pfizer’s Covid-19 antiviral pill Paxlovid over rivals such as Merck’s molnupiravir.The recommendation was based on new trials showing Paxlovid reduced the risk of hospital admission by 85 percent, while molnupiravir has proved significan

Hence then, the article about covid treatments still struggling for mass uptake was published today ( ) and is available on Daily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Covid treatments: Still struggling for mass uptake )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News